US 11878053
Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragments thereof
granted A61KA61K2039/53A61K2039/545
Quick answer
US patent 11878053 (Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragments thereof) held by IO Biotech ApS expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- IO Biotech ApS
- Grant date
- Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/53, A61K2039/545, A61K2039/55522, A61K2039/55527